Sydnthiones are versatile bioorthogonal hydrogen sulfide donors

Abstract

Hydrogen sulfide (H₂S) is an important endogenous gasotransmitter, but the bioorthogonal reaction triggered H₂S donors are still rare. Here we show one type of bioorthogonal H₂S donors, sydnthiones (1,2,3-oxadiazol-3-ium-5-thiolate derivatives), which was designed with the aid of density functional theory (DFT) calculations. The reactions between sydnthiones and strained alkynes provide a platform for controllable, tunable and mitochondria-targeted release of H₂S. We investigate the reactivity of sydnthiones‒dibenzoazacyclooctyne (DIBAC) reactions and their orthogonality with two other bioorthogonal cycloaddition pairs: tetrazine‒norbornene (Nor) and tetrazine‒monohydroxylated cyclooctyne (MOHO). By taking advantage of these mutually orthogonal reactions, we can realize selective labeling or drug release. Furthermore, we explore the role of H₂S, which is released from the sydnthione-DIBAC reaction, on doxorubicin-induced cytotoxicity. The results demonstrate that the viability of H9c2 cells can be significantly improved by pretreating with sydnthione 1b and DIBAC for 6 h prior to exposure to Dox.

Hydrogen sulfide (H₂S) is an important endogenous gasotransmitter, but the bioorthogonal H₂S donors are limited. Here, the authors design and synthesize sydnthiones, and investigate their bioorthogonal reactions with strained alkynes for mitochondria-targeted H₂S release.